XML 59 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
PRODUCT DEVELOPMENT EXPENSES
 12 Months Ended
Dec. 31, 2012
Research and Development [Abstract]  
Research, Development, and Computer Software Disclosure [Text Block]
7. PRODUCT DEVELOPMENT EXPENSES

 

In 1999, we shifted the primary focus of our product development efforts from human applications of our whey protein purification technology to scientifically-proven and practical products that result in a measurable economic impact on animal health and productivity in the dairy and beef industries. We expect to continue this strategic focus. As anticipated, we reduced product development expenses during the year ended December 31, 2012 primarily because we are spending less money on the development of Mast OutÒ with the significant clinical studies now largely complete. We decreased product development expenses by 47%, or $802,455, to $917,600 during the year ended December 31, 2012 in comparison to $1,720,055 during the same period in 2011.